OraSure (OSUR) received a takeover approach from healthcare entrepreneur Ron Zwanziger, Reuters’ Svea Herbst-Bayliss reports. According to three people familiar with the matter, last month Zwanziger submitted an unsolicited all-cash proposal of $3.50-$4.00 a share for OraSure. The company’s board rejected the offer not long after it was sent, without any discussions between the parties, the three sources say.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OSUR:
- OraSure launches novel blood collection device for proteomic research
- OraSure files $300M mixed securities shelf
- Hold Rating on Orasure Technologies Amid 23andMe Acquisition and Revenue Uncertainties
- Evercore says 23andMe buyout removes downside case for OraSure
- OraSure up 5% to $2.55 after Evercore sees downside case removed